HealthEquity, Inc. $HQY Stake Lifted by Amundi

Key Points

• Amundi significantly increased its stake in HealthEquity, Inc. (HQY) by acquiring 27,625 additional shares, raising its total holdings to $2.29 million.
• Institutional investors hold 99.55% of HealthEquity's stock, indicating strong institutional interest and confidence in the company's prospects.
• HealthEquity's stock has received multiple upgrades from analysts, with target prices now ranging from $115.00 to $134.00, and a consensus rating of "Buy".

Amundi grew its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 690,625.0% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 27,629 shares of the company's stock after purchasing an additional 27,625 shares during the quarter. Amundi's holdings in HealthEquity were worth $2,292,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of HQY. Versant Capital Management Inc acquired a new position in shares of HealthEquity during the first quarter worth about $28,000. WPG Advisers LLC acquired a new stake in HealthEquity during the 1st quarter valued at approximately $28,000. Northwestern Mutual Wealth Management Co. increased its holdings in HealthEquity by 176.4% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company's stock worth $58,000 after purchasing an additional 418 shares during the last quarter. Larson Financial Group LLC raised its position in shares of HealthEquity by 1,366.0% in the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company's stock valued at $61,000 after purchasing an additional 642 shares in the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S acquired a new position in shares of HealthEquity in the 1st quarter valued at approximately $65,000. Institutional investors and hedge funds own 99.55% of the company's stock.

Insider Buying and Selling at HealthEquity

In other news, EVP Michael Henry Fiore sold 1,794 shares of the business's stock in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $101.73, for a total value of $182,503.62. Following the completion of the sale, the executive vice president directly owned 53,225 shares in the company, valued at approximately $5,414,579.25. The trade was a 3.26% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.50% of the company's stock.

HealthEquity Stock Performance

Shares of NASDAQ HQY traded up $0.15 during trading on Friday, reaching $92.49. The stock had a trading volume of 616,085 shares, compared to its average volume of 1,219,389. HealthEquity, Inc. has a one year low of $74.07 and a one year high of $116.65. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23. The stock has a market cap of $7.97 billion, a PE ratio of 56.05, a P/E/G ratio of 1.32 and a beta of 0.50. The firm's 50 day moving average price is $93.46 and its two-hundred day moving average price is $94.42.

Analyst Ratings Changes

A number of brokerages have issued reports on HQY. JMP Securities upped their target price on HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research report on Wednesday, June 4th. Wall Street Zen raised HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. JPMorgan Chase & Co. upped their target price on HealthEquity from $125.00 to $126.00 and gave the company an "overweight" rating in a research report on Wednesday, September 3rd. Barrington Research reaffirmed an "outperform" rating and issued a $125.00 target price on shares of HealthEquity in a research report on Friday, August 29th. Finally, Royal Bank Of Canada upped their target price on HealthEquity from $109.00 to $110.00 and gave the company an "outperform" rating in a research report on Wednesday, September 3rd. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Buy" and an average price target of $119.77.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.